证券日报网讯10月15日晚间，东宝生物（300239）发布公告称，自2025年9月17日至2025年10月15日， 包头东宝生物技术股份有限公司(以下简称"公司")股票已有十五个交易日的收盘价低于当期转股价格 6.63元/股的90%，已触发"东宝转债"转股价格向下修正条件。公司于2025年10月15日召开第九届董事会 第十三次会议，审议通过了《关于不向下修正"东宝转债"转股价格的议案》，公司董事会决定本次不向 下修正"东宝转债"转股价格，同时自本次董事会审议通过次一交易日起至2026年4月15日，如再次触 发"东宝转债"转股价格向下修正条件，亦不提出向下修正方案。在此期间之后(从2026年4月16日重新起 算)，若再次触发"东宝转债"转股价格向下修正条件，届时公司董事会将再次召开会议决定是否行使"东 宝转债"的转股价格向下修正权利。 ...

Core Viewpoint - The article discusses the status of various convertible bonds, highlighting which bonds are subject to strong redemption, which are not, and providing details on their trading and conversion values [1][2]. Group 1: Convertible Bonds Status - Sheng 24 Convertible Bond is subject to strong redemption [1][2]. - Dongbao Convertible Bond, Zhengyuan Convertible Bond 02, and Yifeng Convertible Bond are not subject to adjustment [1][2]. - Huicheng Convertible Bond, Xinzhi Convertible Bond, and Tairui Convertible Bond are not subject to strong redemption [1][2]. Group 2: Trading and Conversion Details - The current price of Sanyang Convertible Bond is 126.154, with a strong redemption price of 100.490, and a conversion value of 127.38 [4]. - The current price of Zhongchen Convertible Bond is 135.377, with a strong redemption price of 100.580, and a conversion value of 135.93 [4]. - The current price of Jingxing Convertible Bond is 196.000, with a strong redemption price of 100.290, and a conversion value of 195.58 [4]. - The current price of PuFa Convertible Bond is 110.364, with a redemption price of 110.000, and a conversion value of 105.28 [6].

Group 1 - The company announced that from September 17, 2025, to September 30, 2025, its stock price has been below the current conversion price of 6.63 yuan per share for ten trading days, which is 90% of the conversion price [1] - This situation is expected to trigger the downward adjustment condition for the "Dongbao Convertible Bonds" conversion price [1] - If the conversion price adjustment condition is triggered, the company will follow the provisions of the "Prospectus" to timely fulfill subsequent review procedures and information disclosure obligations [1]

Core Points - The company Baotou Dongbao Biotechnology Co., Ltd. announced that from September 17 to September 30, 2025, its stock closing price has been below 90% of the current conversion price of 6.63 CNY per share for ten trading days, which is expected to trigger the downward adjustment condition for the "Dongbao Convertible Bonds" [1] - The total issuance amount of "Dongbao Convertible Bonds" is 455 million CNY, which was listed on August 18, 2023, with a conversion period from February 5, 2024, to July 30, 2029 [1] - If the adjustment condition is triggered, the company's board of directors has the authority to decide whether to propose an adjustment plan and submit it for shareholder meeting review, while fulfilling the necessary review procedures and information disclosure obligations [1]

Core Points - The company, Dongbao Biological Technology Co., Ltd., has announced the interest payment details for its convertible bonds, known as "Dongbao Convertible Bonds" [1][2] - The interest rate for the bonds is set at 0.50%, with specific interest payments of 5.00 RMB (including tax) for every ten bonds held [1][2] - The bonds were issued on July 31, 2023, with a total of 4,550,000 bonds available for investors [1] Interest Payment Details - The interest payment period is from July 31, 2024, to July 30, 2025, with interest paid annually [1][2] - The interest payment record date is set for July 30, 2025, and investors who sell the bonds before this date will not receive the interest payment [1][3] - The company will not pay interest for the current and future periods to bondholders who convert their bonds into company stock before the interest payment record date [1][4] Taxation Information - Individual bondholders are subject to a personal income tax rate of 20% on the interest earned, which will be withheld by the payment agent [4][5] - Foreign institutional investors are exempt from corporate income tax and value-added tax on the interest income from these bonds until December 31, 2025 [5]

Core Points - Dongbao Biological (300239) closed at 5.6 yuan on June 13, 2025, a 0.36% increase from the previous week's 5.58 yuan [1] - The company has a total market capitalization of 3.324 billion yuan, ranking 45th out of 50 in the bioproducts sector and 3972nd out of 5150 in the A-share market [1] Company Announcements - Dongbao Biological announced a cash dividend of 0.25 yuan per 10 shares (including tax) for the 2024 fiscal year, with the record date on June 16, 2025, and the ex-dividend date on June 17, 2025 [1][4] - The company will not issue new shares or use capital reserves for this dividend distribution, and the remaining undistributed profits will be carried forward to future distributions [1] - The adjusted cash dividend per 10 shares after the distribution will be approximately 0.245546 yuan (including tax) [1] Convertible Bond Adjustments - The conversion price for Dongbao Convertible Bonds (123214) will be adjusted from 6.65 yuan to 6.63 yuan per share, effective June 17, 2025 [2][4] - The company issued 455 million yuan worth of convertible bonds, with a total of 4.55 million bonds available for conversion [2] Share Buyback Adjustments - Following the 2024 dividend distribution, the maximum buyback price will be adjusted from 8.00 yuan to 7.98 yuan per share, with the expected buyback quantity adjusted to between 6,265,700 and 12,531,300 shares [3][4] - The buyback plan was approved on January 3, 2025, with a duration of 12 months [3]

预案为：以公司 2024 年度权益分派实施公告中确定的股权登记日当日的公司总 股本扣除回购专用证券账户中已回购股份数后的股本为基数，向全体股东每 10 股派发现金红利人民币 0.25 元(含税)，不送红股，不以资本公积金转增股本。 公司剩余未分配利润结转以后年度分配。 相关规定，公司回购专户中的股份不参与本次权益分派，故本次分派方案未以公 司现有总股本为分配基数。本次权益分派实施后，按公司现有总股本折算的每 按公司总股本（含公司回购专户已回购股份）折算的每 10 股现金红利(含税)= 实际现金分红总额÷总股本（含公司回购专户已回购股份）×10=583,034,533× （保留六位小数，最后一位直接截取，不四舍五入）。本次权益分派实施后,除 权除息参考价=股权登记日收盘价-按总股本（含回购股份）折算的每股现金红利 =股权登记日收盘价-0.0245546。 证券代码：300239 证券简称：东宝生物 公告编号：2025-047 债券代码：123214 债券简称：东宝转债 包头东宝生物技术股份有限公司 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 包头东 ...

Group 1 - The company has issued convertible bonds amounting to 455 million yuan, with a face value of 100 yuan per bond, totaling 4,550,000 bonds [1] - The initial conversion price for the convertible bonds was set at 6.67 yuan per share, which has been adjusted to 6.65 yuan per share effective from May 31, 2024 [2] - The adjusted conversion price after the latest cash dividend distribution is 6.63 yuan per share, effective from June 17, 2025 [4] Group 2 - The company will adjust the conversion price based on various corporate actions such as stock dividends, capital increases, and cash dividends, following specific formulas [1][2] - The company will disclose any adjustments to the conversion price through official announcements on the Shenzhen Stock Exchange or other designated media [2] - The company has a profit distribution plan for 2024, which does not include stock dividends or capital increases, and will carry forward undistributed profits to future distributions [3]

Core Viewpoint - The company announces a temporary suspension of the conversion of its convertible bonds, effective from June 9, 2025, until the equity registration date for the 2024 annual equity distribution, to ensure the smooth implementation of the distribution [1] Group 1: Convertible Bonds Information - The convertible bonds (code: 123214; name: Dongbao Convertible Bonds) will be suspended for conversion during the specified period but will continue to trade normally [1] - The company will adjust the conversion price of the bonds in the event of stock dividends, capital increases, new share issuances, rights issues, or cash dividends, following a specific formula [1][2] - The adjustment formulas for the conversion price are detailed, including variables for stock dividends, new share prices, and cash dividends [1] Group 2: Price Adjustment Procedures - The company will publish announcements regarding the adjustment of the conversion price on the Shenzhen Stock Exchange website or other designated media, including the adjustment date and method [2] - In cases of share buybacks, mergers, splits, or other events affecting share categories or quantities, the company will adjust the conversion price to protect the rights of bondholders [2]